Title | Creator | Relation Is Part Of | ||
---|---|---|---|---|
126 | Transient, Recurrent, Spontaneous Oculomotor Palsy in Normal Patients | Michael S. Lee; Robert A. Egan; William T. Shults; Simmons Lessell | ||
127 | Transorbital Penetrating Brainstem Injuries: A Report of Three Cases | Laurel M. Quinn; Robert A. Egan; William T. Shults | ||
128 | The Trigeminal Autonomic Cephalgias | Peter J. Goadsby | ||
129 | Unilateral Blepharoptosis and Hering's Law | Timothy J. McCulley; Melanie H. Erb; Robert C. Kersten | ||
130 | Usage of Rapamune (Sirolimus) in the Treatment of Muslinoma | Kiran Kumar Vallam; David I. Kaufman | ||
131 | Validation of a 10-Item Neuro-Ophthalmic Supplement to the VFQ-25 | Brian A. Raphael; Kristin M. Galetta; M. Ligia Nano-Schiavi; Dina A. Jacobs; Clyde E. Markowitz; Steven L. Galetta; Judy A. Shea; Maureen G. Maguire; Carol M. Mangione; Laura J. Balcer | ||
132 | Vision Restoration Therapy (VRT) After Brain Damage: Retrospective Analysis of 300 Patients and Confirmation of Restoration by Retina-stabilized Perimetry | Bernard A. Sabel; B. Herwig; Iris Mueller | ||
133 | Visual Dysfunction in MS Is Associated with Abnormalities in Normal-Appearing Gray and White Matter | Laura J. Balcer; Gregory F. Wu; Jayaram K. Udupa; Tianhu Lei; Tad Iwanaga; Eric D. Schwartz; Lisa M. Desiderio; M. Ligia Nano-Schiavi; Steven L. Galetta; Maureen G. Maguire; Gary R. Cutter | ||
134 | Visual Fields in the Ischemic Optic Neuropathy Treatment Trial at Baseline and Follow-up | Steven E. Feldon; Lori Levin; Roberta W. Scherer; Anthony C. Arnold; Sophia M. Chung; Lenworth N. Johnson; Gregory S. Kosmorsky; Steven A. Newman; Joanne S. Katz; Patricia W. Langenberg; P. David Wilson; Shalom E. Kelman; Kay Dickersin | ||
135 | When All Else Fails, Lay on Hands | Roger E. Turbin; Larry P. Frohman; Jeffrey J. Farkas; Neena M. Mirani; Salvador A. Cuadra; Frank T. Padberg |